← Evidence map

ArticleAtherosclerosis plus2022

Risk stratification and lipid evaluation in mexican patients, evidence of lipid and cardiovascular analysis in REMECAR. The mexican registry of cardiovascular diseases (REMECAR group).

Manuel Odín De Los Ríos-Ibarra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36643798